Colitis, Microscopic clinical trials
The registry lists 23 studies for Colitis, Microscopic across more than 10 countries. 6 are recruiting or about to start. 20 of them are mainly about Colitis, Microscopic (how this is decided). Per ClinicalTrials.gov, last updated 2026-10-26.
Get an email when these change. Save the Colitis, Microscopic studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Status
Who runs them
Technische Universität Dresden (2) · Örebro University, Sweden (2) · Hospital Mutua de Terrassa (2) · Mayo Clinic (2) · Maastricht University Medical Center (2) · Eugene F Yen, MD (1) · Viome (1) · Norwegian University of Science and Technology (1)
What is being tested here
Drugs under test in Colitis, Microscopic studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted
Coming up
Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.
All 2
Who these studies take
Of the 4 Colitis, Microscopic studies recruiting now, 4 (100%) set no upper age limit and 0 (0%) stop at 75 or younger. 0 (0%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 1 (25%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 0 (0%) | 0 (0%) |
| 18 | 2 (50%) | 2 (50%) |
| 30 | 2 (50%) | 2 (50%) |
| 40 | 3 (75%) | 3 (75%) |
| 50 | 4 (100%) | 4 (100%) |
| 65 | 4 (100%) | 4 (100%) |
| 75 | 4 (100%) | 4 (100%) |
| 85 | 4 (100%) | 4 (100%) |
Across all 23 studies, recruiting or not: 13% stop at 75 or younger and 9% at 65; 0% take children; 0% are for women only and 0% for men only; 17% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
Studies
Recruiting first, then most recently updated. Showing 23 of 23. search them.
- A Study to Investigate the Efficacy and Safety of SAR444336 in Adults With Microscopic Colitis in Clinical RemissionRecruitingNCT07156175Phase 29 countries
- Enabling Microbiomics- Driven Personalized NutritionEnrolling by invitationNCT066570011 country
- Mucosa Adherent Intestinal Microbiome in Microscopic Colitis and Colorectal CancerRecruitingNCT061726471 country
- External Validation of a Microscopic Colitis Clinical Scoring System in Patients With Chronic Watery DiarrhoeaRecruitingNCT060310641 country
- Faecal Microbiota Transplantation for Microscopic ColitisNot yet recruitingNCT05998174Early Phase 1
- Efficacy and Safety of Oral Rifaximin in Patients With Active Microscopic ColitisRecruitingNCT04043897Phase 21 country
- Efficacy and Safety of Budesonide MMX® vs. Budesonide CR for Induction of Remission in Microscopic ColitisActive, not recruitingNCT05915104Phase 21 country
- Chronic Diarrhea Owing to Underlying Microscopic ColitisCompletedNCT065308361 country
- Systems Biology of Gastrointestinal and Related DiseasesTerminatedNCT055794441 country
- Modulation of Intestinal Barrier Function and Inflammation Via Butyrate-promoting Dietary FibreStatus unknownNCT05058131Not applicable1 country
- Identification/Characterization of Changes in Microscopic ColitisStatus unknownNCT030639571 country
- Risk Factors for Microscopic ColitisCompletedNCT026993331 country
- Budesonide for Induction of Remission in Incomplete Microscopic ColitisCompletedNCT02142634Phase 32 countries
- Faecal Microbiota Transplantation in Patients With Microscopic ColitisCompletedNCT03275467Not applicable1 country
- FMT in Inflammatory Bowel DiseaseStatus unknownNCT034770321 country
- Rifaximin-treatment of Collagenous ColitisStatus unknownNCT03658993Phase 3
- Case-Control Study to Identify Risk Factors for Microscopic ColitisCompletedNCT019286671 country
- Ussing Experiments to Evaluate the Role of Medication-induced Microscopic ColitisCompletedNCT02303132Not applicable1 country
- Usefulness of Chromoendoscopy in Diagnosing Microscopic ColitisStatus unknownNCT01504048Not applicable1 country
- Treatment of Microscopic ColitisTerminatedNCT00184171Not applicable1 country
- Trial of Mesalamine for the Treatment of Active Microscopic ColitisCompletedNCT00952952Phase 2/31 country
- Budesonide for Maintenance Treatment of Collagenous ColitisCompletedNCT00180076Phase 31 country
- Budesonide Treatment for Lymphocytic ColitisCompletedNCT00180050Phase 31 country